Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cervical Prostaglandin EP3 Receptor mRNA Expression 48 Hours After Administration of Mifepristone

NCT01224509 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01224509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01224509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cervical Prostaglandin EP3 Receptor mRNA Expression 48 Hours After Administration of Mifepristone
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2004
Completion date
March 31, 2005
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical prostaglandin ep3 receptors, pregnancy